Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $79.21 | $17.68 | 348.01% | 330.04x | 23.06x | 24.20x | 64.87x | 1.62x | $41.15M | 0.59% | $108.58M | 1.23 | $7.00B | 130.72 | ||
| CORT | CORCEPT THERAPEUTICS INC | $91.61 | $24.17 | 278.97% | 199.15x | 153.53x | 12.44x | 15.41x | 1.42x | $119.79M | 1.25% | $637.99M | 6.11 | $9.74B | -1,417.91 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.37 | $2.83 | 196.14% | 119.57x | 73.49x | 4.53x | 111.06x | 1.14x | $47.52M | 3.33% | $13.01M | 0.08 | $1.59B | 29.79 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $313.04 | $93.31 | 235.47% | 71.80x | 41.80x | 9.70x | 38.87x | 1.50x | $641.34M | 1.54% | $1.08B | 8.09 | $43.05B | 46.57 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $62.77 | $17.32 | 262.36% | 64.05x | 49.17x | 6.37x | 7.97x | 1.73x | $164.23M | 3.42% | $605.69M | 7.92 | $4.65B | 41.70 | ||
| KRYS | KRYSTAL BIOTECH INC | $374.68 | $95.39 | 292.81% | 48.35x | 47.86x | 26.30x | 8.65x | 2.31x | $237.38M | 2.16% | $1.28B | 43.59 | $10.55B | 49.32 | ||
| ADMA | ADMA BIOLOGICS INC | $9.16 | $9.20 | -0.46% | 13.28x | 10.92x | 4.24x | 5.44x | 0.55x | $107.90M | 4.99% | $390.33M | 1.65 | $2.18B | 9.85 | ||
| RPRX | ROYALTY PHARMA PLC | $56.92 | $39.89 | 42.71% | 29.80x | 10.67x | 10.19x | 3.30x | 0.64x | $2.34B | 9.41% | $9.94B | 22.75 | $41.15B | 35.37 | ||
| VCEL | VERICEL CORP | $46.56 | $9.14 | 409.57% | 108.28x | 96.58x | 8.09x | 6.67x | 2.28x | $47.49M | 2.01% | $356.23M | 7.02 | $2.36B | 58.46 | ||
| HALO | HALOZYME THERAPEUTICS INC | $80.78 | $71.33 | 13.25% | 27.29x | 9.73x | 6.33x | 43.62x | 0.49x | $667.65M | 7.00% | $219.64M | 1.86 | $11.41B | 18.30 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.79 | $40.36 | 45.67% | 41.99x | 15.91x | 3.49x | 1.83x | 0.60x | $767.06M | 6.78% | $6.21B | 32.27 | $9.72B | 20.15 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $244.17 | $49.15 | 396.74% | 519.51x | 9.44x | 3.41x | 3.38x | 1.76x | $1.30B | 8.59% | $4.53B | 73.22 | $18.88B | 27.97 | ||
| ASND | ASCENDIS PHARMA A | $267.92 | $80.87 | 231.30% | 28.40x | 18.25x | 16.34x | 28.99x | 2.89x | $52.94M | 0.32% | $574.09M | 9.24 | $17.02B | 182.53 | ||
| TGTX | TG THERAPEUTICS INC | $55.47 | $20.84 | 166.19% | 17.23x | 39.91x | 11.44x | 14.56x | 4.82x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.80B | 58.66 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.01 | $35.82 | 3.33% | 14.63x | 10.14x | 2.38x | 2.35x | 0.55x | $341.79M | 15.97% | $910.35M | 15.75 | $1.71B | 7.23 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $320.42 | $94.38 | 239.49% | 40.56x | 35.30x | 23.21x | 6.44x | 2.04x | $122.22M | 1.92% | $997.32M | 50.16 | $6.76B | 29.96 | ||
| TECH | BIO-TECHNE CORP | $70.92 | $16.75 | 323.37% | 99.89x | 33.99x | 9.16x | 5.32x | 1.83x | $269.60M | 2.43% | $2.09B | 13.34 | $11.18B | 43.69 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.19 | $8.98 | -75.61% | 8.11x | -7.40x | 2.05x | 2.40x | 0.10x | $7.24M | 5.75% | $52.93M | 0.92 | $73.15M | 4.72 | ||
| EXEL | EXELIXIS INC | $55.53 | $31.09 | 78.59% | 17.80x | 17.07x | 6.04x | 7.21x | 1.27x | $917.69M | 6.40% | $1.94B | 7.49 | $13.90B | 13.16 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $529.59 | $167.94 | 215.34% | 31.13x | 27.09x | 11.01x | 6.94x | 2.27x | $3.71B | 2.76% | $19.36B | 76.20 | $130.91B | 24.27 | ||
| UTHR | UNITED THERAPEUTICS CORP | $547.25 | $241.79 | 126.33% | 18.69x | 19.70x | 7.51x | 3.94x | 2.10x | $1.02B | 4.27% | $5.90B | 135.66 | $21.95B | 12.81 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.50 | $2.46 | 42.29% | 14.58x | 14.79x | 2.14x | 3.39x | 0.98x | $4.11M | 1.46% | $82.33M | 1.03 | $214.78M | 10.11 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.50 | $12.79 | 146.33% | 17.40x | 15.81x | 6.45x | 3.81x | 3.26x | $208.13M | 5.40% | $1.01B | 8.28 | $3.10B | 9.26 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $649.81 | $435.86 | 49.09% | 15.27x | 13.80x | 4.53x | 2.17x | 1.03x | $4.11B | 6.09% | $31.42B | 302.15 | $67.87B | 11.81 | ||
| VCYT | VERACYTE INC | $58.00 | $7.62 | 661.53% | 52.25x | 52.30x | 8.51x | 3.44x | 11.03x | $155.34M | 3.37% | $1.34B | 16.90 | $4.40B | 38.26 | ||
| INCY | INCYTE CORP | $115.62 | $64.93 | 78.08% | 15.86x | 14.61x | 4.30x | 4.11x | 1.47x | $1.45B | 6.29% | $5.62B | 28.21 | $19.67B | 10.51 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $19.18 | $3.25 | 489.76% | 31.97x | 5.24x | 0.92x | 1.35x | 71.22x | $109.24M | 5.42% | $1.51B | 14.34 | $2.60B | 31.39 | ||
| MDXG | MIMEDX GROUP INC | $4.07 | $1.24 | 228.07% | 19.38x | -48.34x | 1.55x | 2.50x | 10.21x | $69.36M | 11.47% | $242.94M | 1.64 | $464.03M | 8.52 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.